In 2021, COVID-19 caused about *** deaths per 100,000 population in high-income countries. This statistic displays the leading causes of death in high-income countries in 2021 by deaths per 100,000 population. Mortality from chronic diseases such as cancer and heart diseases are increasing around the world. Chronic deaths are especially prominent in Western countries, but have also recently began to increase in the developing world. Non-communicable disease burden This increase in chronic and degenerative non-communicable diseases globally stems from aging populations, modernization, and rapid urbanization. Though these are all signs of socioeconomic progress, the resulting shift in disease carries a heavy burden for societies. Health expenditure makes up around ** percent or more of the GDP in most high-income countries, and the global spending on medicines is expected to more than double from 2010 to 2027. Non-communicable disease risk factors and prevention In most OECD countries, over 30 percent of adults are overweight. Lack of exercise, poor nutrition, and generally unhealthy lifestyles can often lead to a cluster of symptoms including abnormal blood levels, high blood pressure, and excess body fat, which in turn pose an increased risk of heart disease, stroke, and diabetes. However, most non-communicable diseases are preventable, and their modifiable risk factors can be lowered through lifestyle and behavioral changes.

In 2021, COVID-19 caused around **** million deaths in high-income countries, making it the second leading cause of death. Ischemic heart disease was the number one cause of death in high-income countries that year, causing around **** million deaths. This statistic displays the leading causes of death in high-income countries in 2021 by deaths per 100,000 population.

The leading cause of death in low-income countries worldwide in 2021 was lower respiratory infections, followed by stroke and ischemic heart disease. The death rate from lower respiratory infections that year was 59.4 deaths per 100,000 people. While the death rate from stroke was around 51.6 per 100,000 people. Many low-income countries suffer from health issues not seen in high-income countries, including infectious diseases, malnutrition and neonatal deaths, to name a few. Low-income countries worldwide Low-income countries are defined as those with per gross national incomes (GNI) per capita of 1,045 U.S. dollars or less. A majority of the world’s low-income countries are located in sub-Saharan Africa and South East Asia. Some of the lowest-income countries as of 2023 include Burundi, Sierra Leone, and South Sudan. Low-income countries have different health problems that lead to worse health outcomes. For example, Chad, Lesotho, and Nigeria have some of the lowest life expectancies on the planet. Health issues in low-income countries Low-income countries also tend to have higher rates of HIV/AIDS and other infectious diseases as a consequence of poor health infrastructure and a lack of qualified health workers. Eswatini, Lesotho, and South Africa have some of the highest rates of new HIV infections worldwide. Likewise, tuberculosis, a treatable condition that affects the respiratory system, has high incident rates in lower income countries. Other health issues can be affected by the income of a country as well, including maternal and infant mortality. In 2023, Afghanistan had one of the highest rates of infant mortality rates in the world.

In the United States in 2021, the death rate was highest among those aged 85 and over, with about 17,190.5 men and 14,914.5 women per 100,000 of the population passing away. For all ages, the death rate was at 1,118.2 per 100,000 of the population for males, and 970.8 per 100,000 of the population for women. The death rate Death rates generally are counted as the number of deaths per 1,000 or 100,000 of the population and include both deaths of natural and unnatural causes. The death rate in the United States had pretty much held steady since 1990 until it started to increase over the last decade, with the highest death rates recorded in recent years. While the birth rate in the United States has been decreasing, it is still currently higher than the death rate. Causes of death There are a myriad number of causes of death in the United States, but the most recent data shows the top three leading causes of death to be heart disease, cancers, and accidents. Heart disease was also the leading cause of death worldwide.

Rank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.

This is historical data. The update frequency has been set to "Static Data" and is here for historic value. Updated on 8/14/2024

Fall-Related Death Rate - This indicator shows the rate of fall-related deaths per 100,000 population. Falls are a major cause of preventable death among the elderly and have increased across age groups in the past decade. Causes of fall-related deaths differ between the elderly and young and middle-aged populations, and require different prevention strategies. In 2009, falls accounted for 30% of accidental deaths. Link to Data Details

Purpose: This study aimed to present national mortality data for 2021 in Korea, focusing on overall trends and leading causes of death. Methods: We analyzed cause-of-death statistics derived from death certificates and mortality reports submitted to administrative offices across Korea. The data were coded following the World Health Organization’s guidelines, which designate an underlying cause of death for each case. Results: A total of 317,680 deaths were recorded in 2021—the highest number since the inception of cause-of-death statistics in 1983—marking an increase of 12,732 deaths (4.2%) compared to 2020. The crude death rate (CDR) was 618.9 per 100,000 population, up 25.0 (4.2%) from the previous year. The CDR has been on an upward trend since 2009, when it was 497.3; in 2021, it reached its highest level since data collection began in 1984, surpassing the previous peak of 585.2. Individuals aged 80 or older accounted for 50.0% of total deaths, representing a 15.2 percentage-point increase from a decade earlier. The top 10 causes of death were malignant neoplasms (cancer), heart disease, pneumonia, cerebrovascular disease, intentional self-harm (suicide), diabetes mellitus, Alzheimer’s disease, liver disease, sepsis, and hypertensive diseases. Conclusion: The sustained growth of Korea’s older adult population has led to an overall increase in both the number of deaths and the CDR. Ongoing attention to emerging mortality trends—such as the rise in sepsis-related deaths—and the persistent burden of chronic conditions is essential.

This table provides an overview of the key figures on health and care available on StatLine. All figures are taken from other tables on StatLine, either directly or through a simple conversion. In the original tables, breakdowns by characteristics of individuals or other variables are possible. The period after the year of review before data become available differs between the data series. The number of exam passes/graduates in year t is the number of persons who obtained a diploma in school/study year starting in t-1 and ending in t.

Data available from: 2001

Status of the figures:

2024: Most available figures are definite. Figures are provisional for: - causes of death; - youth care; - persons employed in health and welfare; - persons employed in healthcare; - Mbo health care graduates; - Hbo nursing graduates / medicine graduates (university).

2023: Most available figures are definite. Figures are provisional for: - perinatal mortality at pregnancy duration at least 24 weeks; - diagnoses known to the general practitioner; - hospital admissions by some diagnoses; - average period of hospitalisation; - supplied drugs; - AWBZ/Wlz-funded long term care; - physicians and nurses employed in care; - persons employed in health and welfare; - average distance to facilities; - profitability and operating results at institutions. Figures are revised provisional for: - expenditures on health and welfare.

2022: Most available figures are definite. Figures are revised provisional for: - expenditures on health and welfare.

2021: Most available figures are definite, Figures are revised provisional for: - expenditures on health and welfare.f

2020 and earlier: All available figures are definite.

Changes as of 4 July 2025: More recent figures have been added for: - causes of death; - life expectancy; - life expectancy in perceived good health; - self-perceived health; - hospital admissions by some diagnoses; - sickness absence; - average period of hospitalisation; - contacts with health professionals; - youth care; - smoking, heavy drinkers, physical activity; - overweight; - high blood pressure; - physicians and nurses employed in care; - persons employed in health and welfare; - persons employed in healthcare; - Mbo health care graduates; - Hbo nursing graduates / medicine graduates (university); - expenditures on health and welfare; - profitability and operating results at institutions.

Changes as of 18 december 2024: - Distance to facilities: the figures withdrawn on 5 June have been replaced (unchanged). - Youth care: the previously published final results for 2021 and 2022 have been adjusted due to improvements in the processing. - Due to a revision of the statistics Expenditure on health and welfare 2021, figures for expenditure on health and welfare care have been replaced from 2021 onwards. - Due to the revision of the National Accounts, the figures on persons employed in health and welfare have been replaced for all years. - AWBZ/Wlz-funded long term care: from 2015, the series Wlz residential care including total package at home has been replaced by total Wlz care. This series fits better with the chosen demarcation of indications for Wlz care.

When will new figures be published? New figures will be published in December 2025.

This statistic shows the percentage changes in selected causes of death due to diseases in the United States, between 2000 and 2022. The number of deaths caused by prostate cancer increased by 7.4 percent during this period. Changes in selected causes of deathThere has been a decrease in the rate of death caused by many diseases, including stroke and heart disease. However, the mortality rate due to Alzheimer’s disease increased by 142 percent from 2000 to 2022. Alzheimer’s disease caused 27.7 deaths per 100,000 population in 2023, making it the sixth leading cause of death in the United States. Mortality rates due to different diseases vary by different factors, including race and ethnicity. For example, cancer is the leading cause of death among Asians and Pacific Islanders in the United States, accounting for 22 percent of total deaths among this population, while heart disease is the leading cause of death among the white population. Ischemic heart disease is the leading cause of death worldwide, accounting for around nine million deaths in 2021. In the early 1900's, the mortality rate was primarily concentrated among people of younger ages, but increasingly, this has shifted to older population groups. In recent years, decreased mortality rates are often linked to improved medical care, such as new developments in medical technologies. Shifts in lifestyle habits such as decreased smoking rates and healthier diets may also attribute to lower mortality rates.

BackgroundDecades of steady improvements in life expectancy in Europe slowed down from around 2011, well before the COVID-19 pandemic, for reasons which remain disputed. We aimed to assess how changes in risk factors and cause-specific death rates in different European countries related to changes in life expectancy in those countries before and during the COVID-19 pandemic.MethodsWe used data and methods from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 to compare changes in life expectancy at birth, causes of death, and population exposure to risk factors in 16 European Economic Area countries (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, and Sweden) and the four UK nations (England, Northern Ireland, Scotland, and Wales) for three time periods: 1990–2011, 2011–19, and 2019–21. Changes in life expectancy and causes of death were estimated with an established life expectancy cause-specific decomposition method, and compared with summary exposure values of risk factors for the major causes of death influencing life expectancy.FindingsAll countries showed mean annual improvements in life expectancy in both 1990–2011 (overall mean 0·23 years [95% uncertainty interval [UI] 0·23 to 0·24]) and 2011–19 (overall mean 0·15 years [0·13 to 0·16]). The rate of improvement was lower in 2011–19 than in 1990–2011 in all countries except for Norway, where the mean annual increase in life expectancy rose from 0·21 years (95% UI 0·20 to 0·22) in 1990–2011 to 0·23 years (0·21 to 0·26) in 2011–19 (difference of 0·03 years). In other countries, the difference in mean annual improvement between these periods ranged from –0·01 years in Iceland (0·19 years [95% UI 0·16 to 0·21] vs 0·18 years [0·09 to 0·26]), to –0·18 years in England (0·25 years [0·24 to 0·25] vs 0·07 years [0·06 to 0·08]). In 2019–21, there was an overall decrease in mean annual life expectancy across all countries (overall mean –0·18 years [95% UI –0·22 to –0·13]), with all countries having an absolute fall in life expectancy except for Ireland, Iceland, Sweden, Norway, and Denmark, which showed marginal improvement in life expectancy, and Belgium, which showed no change in life expectancy. Across countries, the causes of death responsible for the largest improvements in life expectancy from 1990 to 2011 were cardiovascular diseases and neoplasms. Deaths from cardiovascular diseases were the primary driver of reductions in life expectancy improvements during 2011–19, and deaths from respiratory infections and other COVID-19 pandemic-related outcomes were responsible for the decreases in life expectancy during 2019–21. Deaths from cardiovascular diseases and neoplasms in 2019 were attributable to high systolic blood pressure, dietary risks, tobacco smoke, high LDL cholesterol, high BMI, occupational risks, high alcohol use, and other risks including low physical activity. Exposure to these major risk factors differed by country, with trends of increasing exposure to high BMI and decreasing exposure to tobacco smoke observed in all countries during 1990–2021.InterpretationThe countries that best maintained improvements in life expectancy after 2011 (Norway, Iceland, Belgium, Denmark, and Sweden) did so through better maintenance of reductions in mortality from cardiovascular diseases and neoplasms, underpinned by decreased exposures to major risks, possibly mitigated by government policies. The continued improvements in life expectancy in five countries during 2019–21 indicate that these countries were better prepared to withstand the COVID-19 pandemic. By contrast, countries with the greatest slowdown in life expectancy improvements after 2011 went on to have some of the largest decreases in life expectancy in 2019–21. These findings suggest that government policies that improve population health also build resilience to future shocks. Such policies include reducing population exposure to major upstream risks for cardiovascular diseases and neoplasms, such as harmful diets and low physical activity, tackling the commercial determinants of poor health, and ensuring access to affordable health services.

The leading causes of death in Massachusetts are cancer, heart disease, unintentional injury, stroke, and chronic lower respiratory disease. These mortality rates tend to be higher for people of color; and Black residents have a higher premature mortality rate overall and Asian residents have a higher rate of mortality due to stroke.

Excess Deaths excl COVID: Predicted: Above Expected: Arkansas data was reported at 0.000 Number in 30 Oct 2021. This stayed constant from the previous number of 0.000 Number for 23 Oct 2021. Excess Deaths excl COVID: Predicted: Above Expected: Arkansas data is updated weekly, averaging 0.000 Number from Jan 2017 (Median) to 30 Oct 2021, with 251 observations. The data reached an all-time high of 93.000 Number in 07 Aug 2021 and a record low of 0.000 Number in 30 Oct 2021. Excess Deaths excl COVID: Predicted: Above Expected: Arkansas data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G012: Number of Excess Deaths: by States: All Causes excluding COVID-19: Predicted (Discontinued).

United States Excess Deaths: Above Expected: Texas data was reported at 0.000 Number in 30 Oct 2021. This stayed constant from the previous number of 0.000 Number for 23 Oct 2021. United States Excess Deaths: Above Expected: Texas data is updated weekly, averaging 0.000 Number from Jan 2017 (Median) to 30 Oct 2021, with 251 observations. The data reached an all-time high of 2,674.000 Number in 16 Jan 2021 and a record low of 0.000 Number in 30 Oct 2021. United States Excess Deaths: Above Expected: Texas data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G010: Number of Excess Deaths: by States: All Causes (Discontinued).

From 2018 to 2023, heart disease and cancer accounted for the highest share of deaths in the United States. In 2020 and 2021, COVID-19 became the third leading cause of death, accounting for around 12 percent of all deaths in 2021. However, by 2023, COVID-19 was responsible for only 1.6 percent of deaths, making it the tenth leading cause of death. This statistic shows the distribution of the 10 leading causes of death in the United States from 2018 to 2023.

The graph illustrates the number of deaths per day in the United States from 1950 to 2025. The x-axis represents the years, abbreviated from '50 to '24, while the y-axis indicates the daily number of deaths. Over this 75-year period, the number of deaths per day ranges from a low of 4,054 in 1950 to a high of 9,570 in 2021. Notable figures include 6,855 deaths in 2010 and 8,333 in 2024. The data shows a general upward trend in daily deaths over the decades, with recent years experiencing some fluctuations. This information is presented in a line graph format, effectively highlighting the long-term trends and yearly variations in daily deaths across the United States.

National distribution of all-cause mortality by select causes of death, ages 25+.

Note: DPH is updating and streamlining the COVID-19 cases, deaths, and testing data. As of 6/27/2022, the data will be published in four tables instead of twelve.

The COVID-19 Cases, Deaths, and Tests by Day dataset contains cases and test data by date of sample submission. The death data are by date of death. This dataset is updated daily and contains information back to the beginning of the pandemic. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-Cases-Deaths-and-Tests-by-Day/g9vi-2ahj.

The COVID-19 State Metrics dataset contains over 93 columns of data. This dataset is updated daily and currently contains information starting June 21, 2022 to the present. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-State-Level-Data/qmgw-5kp6 .

The COVID-19 County Metrics dataset contains 25 columns of data. This dataset is updated daily and currently contains information starting June 16, 2022 to the present. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-County-Level-Data/ujiq-dy22 .

The COVID-19 Town Metrics dataset contains 16 columns of data. This dataset is updated daily and currently contains information starting June 16, 2022 to the present. The data can be found at https://data.ct.gov/Health-and-Human-Services/COVID-19-Town-Level-Data/icxw-cada . To protect confidentiality, if a town has fewer than 5 cases or positive NAAT tests over the past 7 days, those data will be suppressed.

COVID-19 cases and associated deaths that have been reported among Connecticut residents, broken down by race and ethnicity. All data in this report are preliminary; data for previous dates will be updated as new reports are received and data errors are corrected. Deaths reported to the either the Office of the Chief Medical Examiner (OCME) or Department of Public Health (DPH) are included in the COVID-19 update.

The following data show the number of COVID-19 cases and associated deaths per 100,000 population by race and ethnicity. Crude rates represent the total cases or deaths per 100,000 people. Age-adjusted rates consider the age of the person at diagnosis or death when estimating the rate and use a standardized population to provide a fair comparison between population groups with different age distributions. Age-adjustment is important in Connecticut as the median age of among the non-Hispanic white population is 47 years, whereas it is 34 years among non-Hispanic blacks, and 29 years among Hispanics. Because most non-Hispanic white residents who died were over 75 years of age, the age-adjusted rates are lower than the unadjusted rates. In contrast, Hispanic residents who died tend to be younger than 75 years of age which results in higher age-adjusted rates.

The population data used to calculate rates is based on the CT DPH population statistics for 2019, which is available online here: https://portal.ct.gov/DPH/Health-Information-Systems--Reporting/Population/Population-Statistics. Prior to 5/10/2021, the population estimates from 2018 were used.

Rates are standardized to the 2000 US Millions Standard population (data available here: https://seer.cancer.gov/stdpopulations/). Standardization was done using 19 age groups (0, 1-4, 5-9, 10-14, ..., 80-84, 85 years and older). More information about direct standardization for age adjustment is available here: https://www.cdc.gov/nchs/data/statnt/statnt06rv.pdf

Categories are mutually exclusive. The category “multiracial” includes people who answered ‘yes’ to more than one race category. Counts may not add up to total case counts as data on race and ethnicity may be missing. Age adjusted rates calculated only for groups with more than 20 deaths. Abbreviation: NH=Non-Hispanic.

Data on Connecticut deaths were obtained from the Connecticut Deaths Registry maintained by the DPH Office of Vital Records. Cause of death was determined by a death certifier (e.g., physician, APRN, medical examiner) using their best clinical judgment. Additionally, all COVID-19 deaths, including suspected or related, are required to be reported to OCME. On April 4, 2020, CT DPH and OCME released a joint memo to providers and facilities within Connecticut providing guidelines for certifying deaths due to COVID-19 that were consistent with the CDC’s guidelines and a reminder of the required reporting to OCME.25,26 As of July 1, 2021, OCME had reviewed every case reported and performed additional investigation on about one-third of reported deaths to better ascertain if COVID-19 did or did not cause or contribute to the death. Some of these investigations resulted in the OCME performing postmortem swabs for PCR testing on individuals whose deaths were suspected to be due to COVID-19, but antemortem diagnosis was unable to be made.31 The OCME issued or re-issued about 10% of COVID-19 death certificates and, when appropriate, removed COVID-19 from the death certificate. For standardization and tabulation of mortality statistics, written cause of death statements made by the certifiers on death certificates are sent to the National Center for Health Statistics (NCHS) at the CDC which assigns cause of death codes according to the International Causes of Disease 10th Revision (ICD-10) classification system.25,26 COVID-19 deaths in this report are defined as those for which the death certificate has an ICD-10 code of U07.1 as either a primary (underlying) or a contributing cause of death. More information on COVID-19 mortality can be found at the following link: https://portal.ct.gov/DPH/Health-Information-Systems--Reporting/Mortality/Mortality-Statistics

Data are subject to future revision as reporting changes.

Starting in July 2020, this dataset will be updated every weekday.

Additional notes: A delay in the data pull schedule occurred on 06/23/2020. Data from 06/22/2020 was processed on 06/23/2020 at 3:30 PM. The normal data cycle resumed with the data for 06/23/2020.

A network outage on 05/19/2020 resulted in a change in the data pull schedule. Data from 5/19/2020 was processed on 05/20/2020 at 12:00 PM. Data from 5/20/2020 was processed on 5/20/2020 8:30 PM. The normal data cycle resumed on 05/20/2020 with the 8:30 PM data pull. As a result of the network outage, the timestamp on the datasets on the Open Data Portal differ from the timestamp in DPH's daily PDF reports.

Starting 5/10/2021, the date field will represent the date this data was updated on data.ct.gov. Previously the date the data was pulled by DPH was listed, which typically coincided with the date before the data was published on data.ct.gov. This change was made to standardize the COVID-19 data sets on data.ct.gov.

IntroductionBetween 2021 and 2023, a project was funded in order to explore the mortality burden (YLL–Years of Life Lost, excess mortality) of COVID-19 in Southern and Eastern Europe, and Central Asia.MethodsFor each national or sub-national region, data on COVID-19 deaths and population data were collected for the period March 2020 to December 2021. Unstandardized and age-standardised YLL rates were calculated according to standard burden of disease methodology. In addition, all-cause mortality data for the period 2015–2019 were collected and used as a baseline to estimate excess mortality in each national or sub-national region in the years 2020 and 2021.ResultsOn average, 15–30 years of life were lost per death in the various countries and regions. Generally, YLL rates per 100,000 were higher in countries and regions in Southern and Eastern Europe compared to Central Asia. However, there were differences in how countries and regions defined and counted COVID-19 deaths. In most countries and sub-national regions, YLL rates per 100,000 (both age-standardised and unstandardized) were higher in 2021 compared to 2020, and higher amongst men compared to women. Some countries showed high excess mortality rates, suggesting under-diagnosis or under-reporting of COVID-19 deaths, and/or relatively large numbers of deaths due to indirect effects of the pandemic.ConclusionOur results suggest that the COVID-19 mortality burden was greater in many countries and regions in Southern and Eastern Europe compared to Central Asia. However, heterogeneity in the data (differences in the definitions and counting of COVID-19 deaths) may have influenced our results. Understanding possible reasons for the differences was difficult, as many factors are likely to play a role (e.g., differences in the extent of public health and social measures to control the spread of COVID-19, differences in testing strategies and/or vaccination rates). Future cross-country analyses should try to develop structured approaches in an attempt to understand the relative importance of such factors. Furthermore, in order to improve the robustness and comparability of burden of disease indicators, efforts should be made to harmonise case definitions and reporting for COVID-19 deaths across countries.